BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23631660)

  • 1. Human marrow stromal cells reduce microglial activation to protect motor neurons in a transgenic mouse model of amyotrophic lateral sclerosis.
    Zhou C; Zhang C; Zhao R; Chi S; Ge P; Zhang C
    J Neuroinflammation; 2013 Apr; 10():52. PubMed ID: 23631660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis.
    Zhang C; Zhou C; Teng JJ; Zhao RL; Song YQ; Zhang C
    Cytotherapy; 2009; 11(3):299-306. PubMed ID: 19333801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect and mechanism of marrow stromal cells within cerebrospinal fluid on SOD1 transgenic mice].
    Zhou C; Zhang C; Yao QQ; Zhao CP; Zhang C
    Zhonghua Yi Xue Za Zhi; 2013 Aug; 93(29):2324-8. PubMed ID: 24300157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia and motor neurons during disease progression in the SOD1G93A mouse model of amyotrophic lateral sclerosis: changes in arginase1 and inducible nitric oxide synthase.
    Lewis KE; Rasmussen AL; Bennett W; King A; West AK; Chung RS; Chuah MI
    J Neuroinflammation; 2014 Mar; 11():55. PubMed ID: 24655927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of human marrow stromal cells on activation of microglial cells and production of inflammatory factors induced by lipopolysaccharide.
    Zhou C; Zhang C; Chi S; Xu Y; Teng J; Wang H; Song Y; Zhao R
    Brain Res; 2009 May; 1269():23-30. PubMed ID: 19269277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS.
    Hall ED; Oostveen JA; Gurney ME
    Glia; 1998 Jul; 23(3):249-56. PubMed ID: 9633809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
    Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
    Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
    Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
    J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human mesenchymal stem cell transplantation extends survival, improves motor performance and decreases neuroinflammation in mouse model of amyotrophic lateral sclerosis.
    Vercelli A; Mereuta OM; Garbossa D; Muraca G; Mareschi K; Rustichelli D; Ferrero I; Mazzini L; Madon E; Fagioli F
    Neurobiol Dis; 2008 Sep; 31(3):395-405. PubMed ID: 18586098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis.
    Hemendinger R; Wang J; Malik S; Persinski R; Copeland J; Emerich D; Gores P; Halberstadt C; Rosenfeld J
    Exp Neurol; 2005 Dec; 196(2):235-43. PubMed ID: 16242126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1
    Bursch F; Rath KJ; Sarikidi A; Böselt S; Kefalakes E; Osmanovic A; Thau-Habermann N; Klöß S; Köhl U; Petri S
    J Tissue Eng Regen Med; 2019 Apr; 13(4):649-663. PubMed ID: 30811816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell factor-activated bone marrow ameliorates amyotrophic lateral sclerosis by promoting protective microglial migration.
    Terashima T; Kojima H; Urabe H; Yamakawa I; Ogawa N; Kawai H; Chan L; Maegawa H
    J Neurosci Res; 2014 Jul; 92(7):856-69. PubMed ID: 24936617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human mesenchymal stromal cell transplantation modulates neuroinflammatory milieu in a mouse model of amyotrophic lateral sclerosis.
    Boido M; Piras A; Valsecchi V; Spigolon G; Mareschi K; Ferrero I; Vizzini A; Temi S; Mazzini L; Fagioli F; Vercelli A
    Cytotherapy; 2014 Aug; 16(8):1059-72. PubMed ID: 24794182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis.
    Almer G; Vukosavic S; Romero N; Przedborski S
    J Neurochem; 1999 Jun; 72(6):2415-25. PubMed ID: 10349851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
    J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraspinal bone-marrow cell therapy at pre- and symptomatic phases in a mouse model of amyotrophic lateral sclerosis.
    Gubert F; Decotelli AB; Bonacossa-Pereira I; Figueiredo FR; Zaverucha-do-Valle C; Tovar-Moll F; Hoffmann L; Urmenyi TP; Santiago MF; Mendez-Otero R
    Stem Cell Res Ther; 2016 Mar; 7():41. PubMed ID: 26979533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-Like Receptor-4 Inhibitor TAK-242 Attenuates Motor Dysfunction and Spinal Cord Pathology in an Amyotrophic Lateral Sclerosis Mouse Model.
    Fellner A; Barhum Y; Angel A; Perets N; Steiner I; Offen D; Lev N
    Int J Mol Sci; 2017 Aug; 18(8):. PubMed ID: 28763002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
    Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
    Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose-dependent efficacy of ALS-human mesenchymal stem cells transplantation into cisterna magna in SOD1-G93A ALS mice.
    Kim H; Kim HY; Choi MR; Hwang S; Nam KH; Kim HC; Han JS; Kim KS; Yoon HS; Kim SH
    Neurosci Lett; 2010 Jan; 468(3):190-4. PubMed ID: 19879334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.